NHS approach to B12 deficiency: NICE Clinical Knowledge Summaries recommend investigating B12 deficiency in patients presenting with macrocytic anaemia, unexplained neurological symptoms, or risk factors including pernicious anaemia, gastrectomy, malabsorption disorders, metformin use, proton pump inhibitors, or nitrous oxide exposure
Intended for treatment initiation at the 0.25 mg dose and maintenance treatment at the 0.5 mg dose
GLP-1 analogues are large peptide molecules (typically 3040 amino acids in length), which do not readily penetrate the skin's stratum corneumthe outermost protective barrier
Low blood sugar (shakiness, sweating, confusion treat with 15 grams of fast-acting carbohydrate) Annual Preventive Screenings for Diabetic Patients (ADA 2026) This guide is intended for certified professional coders, CDI specialists, CRC practitioners, and CPMA auditors
The role of sunscreen in melasma and postinflammatory hyperpigmentation
The cardiovascular safety of tirzepatide is also being studied in two larger dedicated CVOTs in people with type 2 diabetes, and in people living with overweight and obesity